3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
265
Leukemia, Lymphocytic, Chronic, B-Cell
66
Lymphoma, Large B-Cell, Diffuse
60
Neoplasms, Plasma Cell
50
Lymphoma, Follicular
45
Lymphoma, Mantle-Cell
42
Lymphoma
41
Recurrence
38
Lymphoma, B-Cell, Marginal Zone
31
Leukemia
30
Leukemia, Myeloid, Acute
27
Lymphoma, B-Cell
19
Lymphoma, Non-Hodgkin
17
Myelodysplastic Syndromes
16
Waldenstrom Macroglobulinemia
15
Smoldering Multiple Myeloma
13
Hodgkin Disease
13
Lymphoma, T-Cell, Peripheral
12
Neoplasms
11
Lymphoma, T-Cell
9
Prostatic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Cutaneous
8
Immunoglobulin Light-chain Amyloidosis
8
Burkitt Lymphoma
8
Sezary Syndrome
7
Neoplasm, Residual
7
Mycosis Fungoides
7
Lymphoma, Large-Cell, Anaplastic
7
Leukemia, Plasma Cell
6
Interventions
Acupuncture Therapy
10
Exercise
6
Cryotherapy
6
Paclitaxel
5
Glutamine
4
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
nicotinamide-beta-riboside
1
glutamic acid diethyl ester
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Vitamin B 6
1
Vitamin B 12
1
Ultrasonic Therapy
1
Trimetazidine
1
Therapeutic Touch
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peripheral Nervous System Diseases
×
Lenalidomide
×
Clear all
NCT07025005
2025-11-04
VRd MM Fibrate
Tanta University
Phase 4
Recruiting
44 enrolled